Blog
RSS FeedPosted by Michael Wonder on 16 Mar 2020
HIV drug PrEP to be available across England
15 March 2020 - PrEP will be routinely available across England as part of the government’s aim to end HIV transmission ...
Posted by Michael Wonder on 11 Jul 2019
How Australia could almost eradicate H.I.V. transmissions
10 July 2019 - It took universal health care, political will and a health campaign designed to terrify the public, ...
Posted by Michael Wonder on 02 Jul 2019
HIV diagnoses in Australia hit 18-year low, but there is still a way go
3 July 2019 - Australia has solidified its reputation as a world leader in HIV prevention, recording its lowest number ...
Posted by Michael Wonder on 25 Mar 2019
19,000 Australians now using PBS subsidised anti-HIV drugs
25 March 2019 - About 19,000 Australians have taken advantage of anti-HIV drugs in the first two years of groundbreaking ...
Posted by Michael Wonder on 20 Dec 2018
Decisions relating to the funded brands of some anti-retroviral treatments for HIV
20 December 2018 - PHARMAC is pleased to announce decisions to award sole supply for seven anti-retroviral treatments used in ...
Posted by Michael Wonder on 16 Oct 2018
Proposal to award sole supply and change some anti-retroviral brands
16 October 2018 - PHARMAC is seeking feedback on a proposal to make several changes to funding of anti-retroviral therapies ...
Posted by Michael Wonder on 07 Jun 2018
Rapid rise in anti-HIV PrEP pills linked to drop in condom use
7 June 2018 - PrEP availability may play a part in men’s complacency about the chances of becoming infected, study suggests. ...
Posted by Michael Wonder on 21 Mar 2018
New medicine to help end the transmission of HIV
21 March 2018 - The Australian Government is taking a critical step in helping end the transmission of HIV infection in ...
Posted by Michael Wonder on 20 Oct 2017
National PreP service would be cost effective, research finds
20 October 2017 - Providing pre-exposure prophylaxis treatment to men who have sex with men at high risk of contracting ...
Posted by Michael Wonder on 09 Sep 2016
Proposal relating to two HIV treatments (Tivicay and Kivexa)
9 September 2016 - PHARMAC is seeking feedback on a proposal to list a new treatment for HIV, dolutegravir (Tivicay) and ...
Posted by Michael Wonder on 29 Aug 2016
CADTH recommends the reimbursement of Descovy (emtricitabine with tenofovir alafenamide fumarate)
24 August 2016 - CADTH is in favour of the reimbursement of Gilead's new dual combination product for HIV-1 infection. ...
Posted by Michael Wonder on 28 Aug 2016
CADTH recommends reimbursement of Truvada for PrEP
24 August 2016 - The recommendation comes with conditions. ...
Posted by Michael Wonder on 23 Aug 2016
Brisbane sees 30% drop in HIV infection over 5 year period; HIV medicine Truvada still not on PBS
23 August 2016 - The combination HIV medicines that has led to a significant drop in the number of HIV cases ...
Posted by Michael Wonder on 19 Aug 2016
HIV prevention drug Truvada won't be subsidised in Australia anytime soon
19 August 2016 - An expensive combination product that prevents people from getting HIV won't be funded by taxpayers in Australia ...
Posted by Michael Wonder on 15 Aug 2016
Emtricitabine with tenofovir alafenamide fumarate in HIV infection: additional benefits not covered
15 August 2016 - Deviation from the appropriate comparator therapy/higher loss for certain patients. ...